dr. morris on radium-223 plus docetaxel in patients with bone metastasis from crpc
Published 11 years ago • 354 plays • Length 1:43Download video MP4
Download video MP3
Similar videos
-
1:30
dr. morris on challenges of radium-223 treatment in prostate cancer
-
1:05
dr. morris on novel approaches with radium-223 in mcrpc
-
1:27
dr. morris on bone biomarkers for radium-223 in prostate cancer
-
1:56
dr. antonarakis on sipuleucel-t plus radium-223 in bone-metastatic crpc
-
1:10
dr. dreicer on challenges of radium-223 in prostate cancer
-
3:56
bone-targeted therapy for prostate cancer: radium-223
-
13:46
timing and optimization of radium 223 in castration resistant prostate cancer
-
15:05
radium-223 in bone-metastatic castration-resistant prostate cancer
-
1:34
dr. michael j. morris on radium-223 combination options for mcrpc
-
5:18
pragmatic considerations for early radium-223 in mcrpc
-
10:09
radium-223 in metastatic crpc
-
3:13
radium-223 safety prior to or after chemotherapy
-
2:52
dora trial: radium-223 plus docetaxel for mcrpc
-
13:09
radium-223 alone and with other agents for prostate cancer
-
3:37
radium-223 after abiraterone: symptomatic skeletal events in patients with mcrpc
-
2:10
radium-223 in men with bone mcrpc
-
5:07
optimizing therapy with radium-223 for prostate cancer
-
3:47
bone-migrated prostate cancer and radium-223 therapy
-
3:27
bone supportive therapy and radium-223 for metastatic prostate cancer